Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06987019 · ClinicalTrials.gov registry record · NA

Reliability and Validity of Continuous Inter-limb Stability

A NA study of Amputation, Lower Limb, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06987019: Recruiting NA study of Amputation, Lower Limb, sponsored by VA Office of Research and Development.

NCT06987019 is a NA study of Amputation, Lower Limb that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06987019, a NA study of Amputation, Lower Limb, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

To date, there is no valid and reliable measure of continuous inter-limb stability available to healthcare teams treating people with lower limb loss. Determining these characteristics of this parameter for this population is important because superior stability has been linked to increased physical activity and strength in similar populations, making it a potential vital contributor to mobility improvement of Veterans with limb loss. It is also crucial that healthcare providers can easily measure continuous stability in the clinic instead of relying on expensive laboratory equipment. The overall goals of this study are to determine the reliability and validity of continuous inter-limb stability of Veterans with lower limb loss and determine if this parameter can be captured using accessible wearable technology. Consequently, clinicians can improve continuous stability through proper rehabilitation to positively impact the functional mobility and overall quality of life of Veterans with lower limb loss.

Primary Outcome

Reliability will be evaluated using Deviation Phase using Relative Phase Analysis. Deviation Phase measures the continuous stability of two oscillating segments throughout a cyclical movement. Relative Phase Analysis is a dynamical systems based methodology that is used to calculated the continuous stability of a movement, such as walking. Deviation Phase ranges from 0-180 degrees, with a lower value indicating better organization of the neuromuscular system.

Conditions Studied

Interventions

  • OTHER 3D motion capture, wearable devices, and functional outcome measures

Study Locations (1)

New York

  • VA NY Harbor Healthcare System, New York, NY - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-04-01
Est. Completion 2026-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06987019 shows while recruiting

NCT06987019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Amputation, Lower Limb appearing as the primary indexed condition, and to 1 intervention - of which 3D motion capture, wearable devices, and functional outcome measures is the first listed.

NCT06987019 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06987019 about?

NCT06987019 is a clinical study titled "Reliability and Validity of Continuous Inter-limb Stability". To date, there is no valid and reliable measure of continuous inter-limb stability available to healthcare teams treating people with lower limb loss. Determining these characteristics of this parameter for this population is important because superior stability has been linked to increased physical...

What is the current status of trial NCT06987019?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-04-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06987019 study?

This clinical trial studies the following conditions: Amputation, Lower Limb.

What interventions are being tested in trial NCT06987019?

The interventions under investigation include: 3D motion capture, wearable devices, and functional outcome measures (OTHER).

Who is sponsoring clinical trial NCT06987019?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06987019 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation, Lower Limb

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06987019's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06987019, the US trial registry maintained by the National Library of Medicine. NCT06987019 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.